Daiichi Sankyo reveals its five-year business plan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2013

Singapore: Daiichi Sankyo has announced a new five-year business plan, which will span from April 1, 2013 through March 31, 2018. As part of the new plan, the company said it will work towa...Read more

Daiichi to work with US FDA to solve Ranbaxy quality issue

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the company's majority stakeholder, Daiichi Sankyo, has now made a state...Read more

Takeda gets go ahead for teduglutide in Europe

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: The European Commission (EC) has granted European market authorization for the medicinal product teduglutide (Revestive in Europe) as a once-daily treatment for adult patients wi...Read more

Astellas, UMN pharma to curb influenza in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2014

Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an application for marketing approval of recombinant influenza HA vaccine A...Read more

Big Pharma continues acquisitions

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

The first quarter of 2011 witnessed major deals in the global pharmaceutical space, with April proving to be a big month for M&A activity, with companies making transactions for more th...Read more

Ranbaxy aiming to sell its generics in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma company, Daiichi Sankyo has planned to supply medicines in Japan fro...Read more

Daiichi Sankyo and Asubio merge to streamline operations

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Apr, 2015

Daiichi Sankyo Inc., the US subsidiary of Daiichi Sankyo Company Ltd, will merge with its US-based sister company, Asubio Pharmaceuticals Inc. As a result, Asubio Pharmaceuticals, Inc. proj...Read more

What functional roles do CROs play in APAC?

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Astellas joins hands with Tecnofarma International

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2013

Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecnofarma International to distribute enzalutamide (trade name Xtandi in ...Read more

BSA-CMR Survey: New CRO players emerge in APAC

Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Alchemia gets US patent for oncology platform technology

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Mar, 2013

Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to its platform oncology technology. The patent is being regarded as a ...Read more

Japan to develop vaccine for H7N9 bird flu

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the H7N9 strain of avian influenza, according to a report published by Th...Read more

Kitasato Daiichi Sankyo to shut animal vaccine unit

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine business at the end of FY2013 in order to focus resources on vaccines fo...Read more

OptiMedica expands footprint in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2012

Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Laser System with new installations at the premier Shinagawa LASIK Cente...Read more

WaferGen, Qiagen sign Next-Gen sequencing deal

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in Japan in the areas of genomics platforms such as Next-Gen sequencing ...Read more

Novartis's Ultibro Breezhaler receives EC, Japanese nod

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 85 mcg / glycopyrronium 43 mcg) as a maintenance bronchodilator treatm...Read more

Shimadzu India aims at 15-20% growth

Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connecting with their customers through various initiatives. Recently, it orga...Read more

Ex-GSK boss promoted as Takeda's CEO

Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief operating Officer (COO), as the chief executive officer (CEO) of the ...Read more